DONNELLY CHRISTOPHER J ET AL: "RNA Toxicity from the ALS/FTDC9ORF72Expansion Is Mitigated by Antisense Intervention", NEURON, CELL PRESS, US, vol. 80, no. 2, 16 October 2013 (2013-10-16), pages 415-428, XP028757398, ISSN: 0896-6273, DOI: 10.1016/J.NEURON.2013.10.015 -& Christopher J. Donnelly ET AL: "RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Supplemental Information", Neuron, 16 October 2013 (2013-10-16), XP55508871, Retrieved from the Internet: URL:https://ars.els-cdn.com/content/image/ 1-s2.0-S0896627313009185-mmc1.pdf [retrieved on 2018-09-21] (B1)

DONNELLY ET AL.: 'RNA Toxicity from the ALS/FTD C90RF72 Expansion Is Mitigated by Antisense Intervention' NEURON vol. 80, no. 2, 16 October 2013, pages 415 - 428., XP028757398 (B1)

GIULIETTA RIBOLDI ET AL: "Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases", MOLECULAR NEUROBIOLOGY, vol. 50, no. 3, 9 May 2014 (2014-05-09), pages 721-732, XP55508816, US ISSN: 0893-7648, DOI: 10.1007/s12035-014-8724-7 (B1)

LAGIER-TOURENNE ET AL.: 'Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration' PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES vol. 110, no. 47, 29 October 2013, pages 4530 - 4539, XP055228419 (B1)

SORANA CIURA ET AL: "Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis", ANNALS OF NEUROLOGY., vol. 74, no. 2, 30 May 2013 (2013-05-30), pages 180-187, XP55228421, BOSTON, US ISSN: 0364-5134, DOI: 10.1002/ana.23946 (B1)

WO-A2-2015/054676 (B1)

WO-A1-2013/030588 (B1)

WO-A1-2014/062686 (B1)

WO-A1-2014/062736 (B1)

WO-A1-2014/114660 (B1)

STEPHANIE A. FERNANDES ET AL: "Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective", JOURNAL OF NUCLEIC ACIDS, vol. 2013, 2013, pages 1-11, XP55351557, US ISSN: 2090-0201, DOI: 10.1155/2013/208245 (B1)